These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19207106)
1. Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays. Maretzky T; Yang G; Ouerfelli O; Overall CM; Worpenberg S; Hassiepen U; Eder J; Blobel CP Biochem J; 2009 Apr; 420(1):105-13. PubMed ID: 19207106 [TBL] [Abstract][Full Text] [Related]
2. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression. Lucas N; Day ML J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays. Maretzky T; Swendeman S; Mogollon E; Weskamp G; Sahin U; Reiss K; Blobel CP Biochem J; 2017 Apr; 474(9):1467-1479. PubMed ID: 28264989 [TBL] [Abstract][Full Text] [Related]
4. Characterization of oxygen-induced retinopathy in mice carrying an inactivating point mutation in the catalytic site of ADAM15. Maretzky T; Blobel CP; Guaiquil V Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6774-82. PubMed ID: 25249606 [TBL] [Abstract][Full Text] [Related]
5. Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling. Böhm BB; Aigner T; Roy B; Brodie TA; Blobel CP; Burkhardt H Arthritis Rheum; 2005 Apr; 52(4):1100-9. PubMed ID: 15818704 [TBL] [Abstract][Full Text] [Related]
6. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation. Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333 [TBL] [Abstract][Full Text] [Related]
7. Presence, processing, and localization of mouse ADAM15 during sperm maturation and the role of its disintegrin domain during sperm-egg binding. Pastén-Hidalgo K; Hernández-Rivas R; Roa-Espitia AL; Sánchez-Gutiérrez M; Martínez-Pérez F; Monrroy AO; Hernández-González EO; Mújica A Reproduction; 2008 Jul; 136(1):41-51. PubMed ID: 18390692 [TBL] [Abstract][Full Text] [Related]
8. Critical function for ADAM9 in mouse prostate cancer. Peduto L; Reuter VE; Shaffer DR; Scher HI; Blobel CP Cancer Res; 2005 Oct; 65(20):9312-9. PubMed ID: 16230393 [TBL] [Abstract][Full Text] [Related]
9. Fluorescent substrates for ADAM15 useful for assaying and high throughput screening. Moss ML; Miller MA; Vujanovic N; Yoneyama T; Rasmussen FH Anal Biochem; 2016 Dec; 514():42-47. PubMed ID: 27637923 [TBL] [Abstract][Full Text] [Related]
10. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes. Lee HD; Koo BH; Kim YH; Jeon OH; Kim DS FASEB J; 2012 Jul; 26(7):3084-95. PubMed ID: 22505472 [TBL] [Abstract][Full Text] [Related]
11. Screening cellular proteins involved in the anti-proliferative effect of the ADAM15 disintegrin domain in murine melanoma cells. Wu J; Zhang L; Ma X; Zhang X; Jin J Oncol Rep; 2008 Sep; 20(3):669-75. PubMed ID: 18695922 [TBL] [Abstract][Full Text] [Related]
12. LPS activates ADAM9 dependent shedding of ACE from endothelial cells. English WR; Corvol P; Murphy G Biochem Biophys Res Commun; 2012 Apr; 421(1):70-5. PubMed ID: 22480688 [TBL] [Abstract][Full Text] [Related]
13. Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer. Maretzky T; Le Gall SM; Worpenberg-Pietruk S; Eder J; Overall CM; Huang XY; Poghosyan Z; Edwards DR; Blobel CP Cancer Res; 2009 Jun; 69(11):4573-6. PubMed ID: 19487280 [TBL] [Abstract][Full Text] [Related]
14. ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma. Ungerer C; Doberstein K; Bürger C; Hardt K; Boehncke WH; Böhm B; Pfeilschifter J; Dummer R; Mihic-Probst D; Gutwein P Biochem Biophys Res Commun; 2010 Oct; 401(3):363-9. PubMed ID: 20851104 [TBL] [Abstract][Full Text] [Related]
15. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Mattern J; Roghi CS; Hurtz M; Knäuper V; Edwards DR; Poghosyan Z Sci Rep; 2019 Aug; 9(1):12540. PubMed ID: 31467400 [TBL] [Abstract][Full Text] [Related]
16. A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation. Yang X; Meegan JE; Jannaway M; Coleman DC; Yuan SY Cardiovasc Res; 2018 Nov; 114(13):1752-1763. PubMed ID: 29939250 [TBL] [Abstract][Full Text] [Related]
17. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer. Lorenzatti Hiles G; Bucheit A; Rubin JR; Hayward A; Cates AL; Day KC; El-Sawy L; Kunju LP; Daignault S; Lee CT; Liebert M; Hussain M; Day ML PLoS One; 2016; 11(3):e0150138. PubMed ID: 26930657 [TBL] [Abstract][Full Text] [Related]
18. Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells. Yokozeki T; Wakatsuki S; Hatsuzawa K; Black RA; Wada I; Sehara-Fujisawa A Genes Cells; 2007 Mar; 12(3):329-43. PubMed ID: 17352738 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase). Okada Y Verh Dtsch Ges Pathol; 2007; 91():29-38. PubMed ID: 18314593 [TBL] [Abstract][Full Text] [Related]
20. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. Najy AJ; Day KC; Day ML J Biol Chem; 2008 Jun; 283(26):18393-401. PubMed ID: 18434311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]